medigraphic.com
Colegio de Medicos y Cirujanos República de Costa Rica

2013, Number 606

<< Back Next >>

Rev Med Cos Cen 2013; 70 (606)

A comparable biomarcadores en pacientes con sepsis severa y shock séptico

Estrada RC, Vargas MSF

Language: Spanish
References: 13
Page: 325-330
PDF size: 172.23 Kb.


ABSTRACT

Severe sepsis and septic shock have come to be a challenge in terms of early recognition and proper approach, clinically may exist confusion in differentiate a systemic inflammatory response syndrome (SIRS) and sepsis, which may result in a delay in the diagnosis and treatment, hence lies the importance of defining each term, because a patient can course with noninfectious SIRS and self-limited, in contradiction with severe sepsis which requires early and aggressive approach to improve survival. Currently the use of biomarkers represents a tool for diagnosis, prognosis and decision regarding antibioticotherapy (10, 12)


REFERENCES

  1. Adams, CA. Sepsis Biomarkers in Polytrauma Patients. Crit Care Clin 27 (2011) 345–354

  2. Dellinger, RP y colaboradores. Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008 Vol. 36, No. 1

  3. Georgopoulou, AP y colaboradores. Early changes of procalcitonin may advise about prognosis and appropriateness of antimicrobial therapy in sepsis. Journal of Critical Care (2011) 26, 331.e1–331. e7

  4. Kibe, S y colaboradores. Diagnostic and prognostic biomarkers of sepsis in critical care. J Antimicrob Chemother 2011; 66 Suppl 2: ii33–ii40.

  5. Lichtenstern, C y colaboradores. Predictors of survival in sepsis: what is the best inflammatory marker to measure?. Curr Opin Infect Dis 2012, 25:328–336

  6. Memis, D y colaboradores. High C-reactive protein and low cholesterol levels are prognostic markers of survival in severe sepsis. Journal of Clinical Anesthesia (2007) 19, 186–191

  7. Namas, R y colaboradores. Sepsis: Something old, something new, and a systems view. Journal of Critical Care (2012) 27, 314.e1–314.e11

  8. Pierrakos, C y Vicent JL. Sepsis biomarkers: a review. Critical Care 2010, 14:R15

  9. Sankar, V.Clinical application of sepsis biomarkers. Journal of Anesthesia. 2012 Oct 30. [Epub ahead of print]

  10. Talan, DA y colaboradores. Severe Sepsis and Septic Shock in the Emergency Department. Infect Dis Clin N Am 22 (2008) 1–31

  11. Tang, BTP y colaboradores. Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis. Lancet Infect Disease 2007; 7: 210–17.

  12. Tschaikowsky, S y colaboradores. Predictive value of procalcitonin, interleukin-6, and C-reactive protein for survival in postoperative patients with severe sepsis. Journal of Critical Care (2011) 26, 54–64.

  13. Vincent, JL y colaboradores. Biomarkers in the Critically I l l Patient: C-reactive Protein Critical Care The Clinics 27




2020     |     www.medigraphic.com